Baker BROS. Advisors LP — 13F Holdings

2026 Q3  ·  88 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, BAKER BROS. ADVISORS LP maintained a portfolio of 88 distinct positions. The most significant new addition was First Tracks Biotherapeutics, , now representing 0.08% of the total fund value. They heavily accumulated shares in Kodiak Sciences Inc., increasing the position by 9.7%. The fund also reduced its exposure to Celcuity Inc. by 39.2%.
Position History hover any row below to update
Loading…
BAKER BROS. ADVISORS LP New York, NY Hedge Fund AUM $20,989M
PCA Score Concentration Risk
Risk ENB
Total Positions
88
Quarter
2026 Q3
Top Holding
INCY (17.7%)
Top 10 Concentration
77.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 88

BAKER BROS. ADVISORS LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
INCY
Incyte Corporat...
Healthcare 17.74% 17.48% #1
Prev: #1
6.5
—
322 0.0%
P
S
30,762,652 $3,733,047,820
$56.34 +112.4%
$121.35 -1.4%
2003 Q2 13F Filing 2026-09-30 2026-11-16
ONC
BeOne Medicines...
Healthcare 15.36% 12.57% #2
Prev: #2
6.0
—
30,768 0.3%
P
S
8,832,335 $3,232,104,670
$136.84 +202.0%
$365.94 +12.9%
2016 Q1 13F Filing 2026-09-30 2026-11-16
RVMD
Revolution Medi...
Healthcare 10.38% 10.74% #3
Prev: #3
5.5
—
-806,039 -7.0%
P
S
10,637,318 $2,183,415,893
$56.67 +182.0%
$205.26 -22.1%
2021 Q1 13F Filing 2026-09-30 2026-11-16
KOD
Kodiak Sciences...
Healthcare 9.85% 3.89% #4 5
Prev: #9
6.4
—
1,941,755 9.7%
P
S
21,860,941 $2,072,417,207 2018 Q4 13F Filing 2026-09-30 2026-11-16
MDGL
Madrigal Pharma...
Healthcare 5.13% 5.77% #5 1
Prev: #4
3.6
—
no change no change
P
S
2,143,131 $1,080,052,299 2016 Q3 13F Filing 2026-09-30 2026-11-16
INSM
Insmed Incorpor...
Healthcare 4.77% 4.70% #6 1
Prev: #7
2.9
—
no change no change
P
S
8,796,111 $1,003,988,110 2012 Q4 13F Filing 2026-09-30 2026-11-16
KYMR
Kymera Therapeu...
Healthcare 4.60% 4.97% #7 1
Prev: #6
2.8
—
no change no change
P
S
8,657,242 $967,793,083 2020 Q3 13F Filing 2026-09-30 2026-11-16
ACAD
ACADIA Pharmace...
Healthcare 4.11% 5.44% #8 3
Prev: #5
2.6
—
no change no change
P
S
42,912,904 $864,695,016 2005 Q1 13F Filing 2026-09-30 2026-11-16
GRAL
GRAIL, Inc.
Healthcare 2.68% 1.38% #9 5
Prev: #14
2.1
—
no change no change
P
S
4,028,614 $564,489,394 2024 Q4 13F Filing 2026-09-30 2026-11-16
SMMT
Summit Therapeu...
Healthcare 2.63% 2.39% #10 3
Prev: #13
2.1
—
no change no change
P
S
32,786,348 $554,417,145 2022 Q4 13F Filing 2026-09-30 2026-11-16
RYTM
Rhythm Pharmace...
Healthcare 2.54% 3.12% #11 1
Prev: #10
2.0
—
no change no change
P
S
5,604,483 $533,630,849 2017 Q4 13F Filing 2026-09-30 2026-11-16
PRAX
Praxis Precisio...
Healthcare 2.43% 2.94% #12 1
Prev: #11
2.0
—
no change no change
P
S
1,753,198 $510,583,854 2024 Q1 13F Filing 2026-09-30 2026-11-16
ABCL
AbCellera Biolo...
Healthcare 2.29% 1.30% #13 2
Prev: #15
1.4
—
1 0.0%
P
S
33,012,139 $481,647,108 2020 Q4 13F Filing 2026-09-30 2026-11-16
ALKS
Alkermes plc
Healthcare 1.93% 2.63% #14 2
Prev: #12
1.8
—
no change no change
P
S
10,012,267 $405,697,059 2003 Q3 13F Filing 2026-09-30 2026-11-16
CELC
Celcuity Inc.
Healthcare 1.82% 4.15% #15 7
Prev: #8
0.7
—
-3,100,000 -39.2%
P
S
4,815,792 $382,951,780 2023 Q3 13F Filing 2026-09-30 2026-11-16
KNSA
Kiniksa Pharmac...
Healthcare 1.00% 0.91% #16 2
Prev: #18
1.4
—
no change no change
P
S
2,834,643 $211,492,714 2024 Q2 13F Filing 2026-09-30 2026-11-16
IDYA
IDEAYA Bioscien...
Healthcare 0.91% 0.94% #17
Prev: #17
1.4
—
no change no change
P
S
5,010,030 $192,485,353 2019 Q2 13F Filing 2026-09-30 2026-11-16
EWTX
Edgewise Therap...
Healthcare 0.71% 0.75% #18 4
Prev: #22
1.3
—
no change no change
P
S
3,701,719 $150,289,791 2021 Q1 13F Filing 2026-09-30 2026-11-16
REPL
Replimune Group...
Healthcare 0.69% 0.61% #19 4
Prev: #23
1.3
—
no change no change
P
S
11,045,336 $146,240,249 2020 Q2 13F Filing 2026-09-30 2026-11-16
ROIV
Roivant Science...
Healthcare 0.64% 0.84% #20 1
Prev: #19
0.3
—
-1,056,479 -22.4%
P
S
3,660,352 $133,859,073 2022 Q4 13F Filing 2026-09-30 2026-11-16
ARWR
Arrowhead Pharm...
Healthcare 0.53% 0.81% #21 1
Prev: #20
0.7
—
-283,730 -14.2%
P
S
1,709,053 $111,857,519 2013 Q3 13F Filing 2026-09-30 2026-11-16
NRIX
Nurix Therapeut...
Healthcare 0.52% 0.57% #22 2
Prev: #24
1.2
—
no change no change
P
S
4,658,556 $110,454,363 2020 Q3 13F Filing 2026-09-30 2026-11-16
IMVT
Immunovant, Inc...
Healthcare 0.44% 1.05% #23 7
Prev: #16
0.2
—
-2,664,843 -49.0%
P
S
2,770,377 $93,583,335 2023 Q3 13F Filing 2026-09-30 2026-11-16
CLDX
Celldex Therape...
Healthcare 0.40% 0.22% #24 16
Prev: #40
3.2
—
1,382,373 116.9%
P
S
2,564,984 $83,131,131 2023 Q4 13F Filing 2026-09-30 2026-11-16
DNLI
Denali Therapeu...
Healthcare 0.37% 0.48% #25 3
Prev: #28
1.1
—
no change no change
P
S
3,734,336 $77,188,725 2020 Q1 13F Filing 2026-09-30 2026-11-16
DNTH
Dianthus Therap...
Healthcare 0.36% 0.42% #26 4
Prev: #30
1.1
—
no change no change
P
S
852,164 $75,033,040 2025 Q2 13F Filing 2026-09-30 2026-11-16
N/A
Celcuity Inc.
Bond/Debt 0.26% 0.35% #27 5
Prev: #32
1.1
—
no change no change
P
S
30,750,000 $55,457,225 — 13F Filing 2026-09-30 2026-11-16
RAPP
Rapport Therape...
Healthcare 0.25% 0.32% #28 5
Prev: #33
1.1
—
no change no change
P
S
1,547,090 $51,982,224 2025 Q2 13F Filing 2026-09-30 2026-11-16
GLUE
Monte Rosa Ther...
Healthcare 0.25% 0.53% #29 3
Prev: #26
1.1
—
no change no change
P
S
4,345,736 $51,844,630 2023 Q1 13F Filing 2026-09-30 2026-11-16
RLAY
Relay Therapeut...
Healthcare 0.24% 0.27% #30 6
Prev: #36
1.1
—
no change no change
P
S
2,826,783 $51,023,433 2023 Q1 13F Filing 2026-09-30 2026-11-16
IONS
Ionis Pharmaceu...
Healthcare 0.22% 0.81% #31 10
Prev: #21
0.1
—
-1,023,863 -50.0%
P
S
1,023,864 $45,715,528 2006 Q2 13F Filing 2026-09-30 2026-11-16
GPCR
Structure Thera...
Healthcare 0.21% 0.39% #32 1
Prev: #31
1.1
—
no change no change
P
S
1,432,529 $44,795,182 2024 Q3 13F Filing 2026-09-30 2026-11-16
ELVN
Enliven Therape...
Healthcare 0.20% 0.23% #33 6
Prev: #39
1.1
—
no change no change
P
S
905,191 $41,493,955 2024 Q1 13F Filing 2026-09-30 2026-11-16
BCYC
Bicycle Therape...
Healthcare 0.19% 0.23% #34 4
Prev: #38
1.1
—
no change no change
P
S
10,885,357 $40,058,114 2022 Q3 13F Filing 2026-09-30 2026-11-16
PRLD
Prelude Therape...
Healthcare 0.19% 0.27% #35
Prev: #35
1.1
—
no change no change
P
S
10,123,824 $39,584,152 2020 Q3 13F Filing 2026-09-30 2026-11-16
MIRM
Mirum Pharmaceu...
Healthcare 0.18% 0.26% #36 1
Prev: #37
1.1
—
no change no change
P
S
445,975 $38,121,943 2019 Q3 13F Filing 2026-09-30 2026-11-16
DSGN
Design Therapeu...
Healthcare 0.18% 0.19% #37 5
Prev: #42
2.1
—
309,714 11.6%
P
S
2,988,144 $37,560,970 2021 Q1 13F Filing 2026-09-30 2026-11-16
IMTX
Immatics N.V.
Healthcare 0.18% 0.48% #38 11
Prev: #27
0.1
—
-5,251,883 -55.2%
P
S
4,256,682 $37,373,668 2020 Q3 13F Filing 2026-09-30 2026-11-16
STOK
Stoke Therapeut...
Healthcare 0.16% 0.55% #39 14
Prev: #25
0.1
—
-2,022,698 -60.6%
P
S
1,313,999 $34,163,974 2022 Q3 13F Filing 2026-09-30 2026-11-16
TRDA
Entrada Therape...
Healthcare 0.15% 0.19% #40 3
Prev: #43
1.1
—
no change no change
P
S
5,072,730 $32,211,836 2021 Q4 13F Filing 2026-09-30 2026-11-16
NGNE
Neurogene Inc.
Healthcare 0.13% 0.16% #41 5
Prev: #46
1.1
—
no change no change
P
S
991,691 $27,588,844 2023 Q4 13F Filing 2026-09-30 2026-11-16
XNCR
Xencor, Inc.
Healthcare 0.13% 0.09% #42 18
Prev: #60
1.1
—
no change no change
P
S
1,102,106 $27,497,545 2013 Q4 13F Filing 2026-09-30 2026-11-16
SNSE
Faeth Therapeut...
Healthcare 0.11% 0.16% #43 1
Prev: #44
0.0
—
-482,986 -37.5%
P
S
803,425 $23,893,860 2026 Q2 13F Filing 2026-09-30 2026-11-16
ABSI
Absci Corporati...
Healthcare 0.11% 0.12% #44 7
Prev: #51
1.0
—
no change no change
P
S
2,134,803 $22,991,828 2025 Q4 13F Filing 2026-09-30 2026-11-16
IRON
Disc Medicine, ...
Healthcare 0.11% 0.13% #45 5
Prev: #50
1.0
—
no change no change
P
S
349,657 $22,888,547 2024 Q4 13F Filing 2026-09-30 2026-11-16
RCUS
Arcus Bioscienc...
Healthcare 0.10% 0.13% #46 3
Prev: #49
1.0
—
no change no change
P
S
844,816 $21,821,597 2018 Q2 13F Filing 2026-09-30 2026-11-16
GENB
Generate Biomed...
Healthcare 0.10% 0.12% #47 5
Prev: #52
1.0
—
no change no change
P
S
1,423,602 $21,382,502 2026 Q1 13F Filing 2026-09-30 2026-11-16
TSHA
Taysha Gene The...
Healthcare 0.09% 0.14% #48
Prev: #48
1.0
—
no change no change
P
S
4,004,756 $19,503,162 2023 Q3 13F Filing 2026-09-30 2026-11-16
AKTS
Aktis Oncology,...
Healthcare 0.09% 0.16% #49 4
Prev: #45
1.0
—
no change no change
P
S
996,351 $19,398,954 2026 Q1 13F Filing 2026-09-30 2026-11-16
JBIO
Jade Bioscience...
Healthcare 0.08% 0.14% #50 3
Prev: #47
1.0
—
no change no change
P
S
1,230,426 $17,287,485 2025 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 88 holdings

Unlock Full BAKER BROS. ADVISORS LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →